Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375934 · ClinicalTrials.gov registry record · Phase 3
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
A Phase 3 study of Pain, Postoperative, sponsored by Xanodyne Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 4
- Study locations
NCT00375934: Completed Phase 3 study of Pain, Postoperative, sponsored by Xanodyne Pharmaceuticals.
NCT00375934 is a Phase 3 study of Pain, Postoperative that has completed, run by Xanodyne Pharmaceuticals. The registered enrollment target is 200 participants, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (26% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00375934, a Phase 3 study of Pain, Postoperative, has completed, sponsored by Xanodyne Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.
Primary Outcome
Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain
Conditions Studied
Interventions
- DRUG Placebo
- DRUG diclofenac potassium (XP21L)
Study Locations (4)
Texas
- Investigative Site - Austin
- Investigative Site - Houston
- Investigative Site - San Marcos
Utah
- Investigative Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-09 |
| Phase | Phase 3 |
What the finished NCT00375934 record still lists
NCT00375934 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00375934 reports a single indexed study location in Texas, Utah.
Frequently Asked Questions
What is clinical trial NCT00375934 about?
NCT00375934 is a clinical study titled "Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery". A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.
What is the current status of trial NCT00375934?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2006-09.
What conditions does trial NCT00375934 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT00375934?
The interventions under investigation include: Placebo (DRUG), diclofenac potassium (XP21L) (DRUG).
Who is sponsoring clinical trial NCT00375934?
This trial is sponsored by Xanodyne Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00375934 being conducted?
This trial has 4 study locations across Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00375934's enrollment target sits among peer trials
200 17th of 113 higher than 95 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
-
Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia